Hospitality. That’s the most important word to Dino Passaretta, when he talks about the key to the success of his five Rhode ...

California officials acknowledge illegal sales still far outpace transactions through licensed shops and vendors.

Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 ...

Tech stocks have been volatile — especially Nvidia, which fell 17% after DeepSeek spooked investors. But many of them ...

STORY: U.S. stocks ended higher on Thursday as investors digested a stack of key earnings reports, including from megacap ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

Individual investors responded to the market selloff earlier this week triggered by concerns regarding a Chinese artificial ...

The Bureau of Economic Analysis's advance estimate of US gross domestic product (GDP) in the fourth quarter showed the economy grew at an annualized pace of 2.3%, below the 2.6% expected by economists ...

"Retail investors have (so far) responded to the DeepSeek-induced equity sell-off by doing what they do best: buying the dip." That's from Vanda Research's new bulletin analyzing the trading of ...

New data out of Vanda Research shows individual investors bought $562.2 ... cash flow statement to see how much it's spending ...